February 21, 2025 · Form 4 insider transaction
REESE DAVID M sold 25,225 shares of Amgen Inc. at $304.44 per share, a transaction worth $7.68M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
The price reported is an average price. The prices ranged from $297.19 to $305.33 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer.; These shares include 707 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.